These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
272 related items for PubMed ID: 23520322
1. Use of tiotropium Respimat Soft Mist Inhaler versus HandiHaler and mortality in patients with COPD. Verhamme KM, Afonso A, Romio S, Stricker BC, Brusselle GG, Sturkenboom MC. Eur Respir J; 2013 Sep; 42(3):606-15. PubMed ID: 23520322 [Abstract] [Full Text] [Related]
8. Use of tiotropium Respimat versus HandiHaler and mortality in patients with COPD. Verhamme KM, Sturkenboom MC, Brusselle GG. Eur Respir J; 2014 Jun; 43(6):1818-9. PubMed ID: 24881063 [No Abstract] [Full Text] [Related]
9. Use of tiotropium Respimat versus HandiHaler and mortality in patients with COPD. Meyer CN. Eur Respir J; 2014 Jun; 43(6):1816-8. PubMed ID: 24881062 [No Abstract] [Full Text] [Related]
11. Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switch. Hanada S, Wada S, Ohno T, Sawaguchi H, Muraki M, Tohda Y. Int J Chron Obstruct Pulmon Dis; 2015 Jun; 10():69-77. PubMed ID: 25609941 [Abstract] [Full Text] [Related]
12. A dose-ranging study of tiotropium delivered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients. Caillaud D, Le Merre C, Martinat Y, Aguilaniu B, Pavia D. Int J Chron Obstruct Pulmon Dis; 2007 Jun; 2(4):559-65. PubMed ID: 18268929 [Abstract] [Full Text] [Related]
13. Tiotropium Handihaler and the risk of cardio- or cerebrovascular events and mortality in patients with COPD. Verhamme KM, Afonso AS, van Noord C, Haag MD, Koudstaal PJ, Brusselle GG, Sturkenboom MC. Pulm Pharmacol Ther; 2012 Feb; 25(1):19-26. PubMed ID: 22051450 [Abstract] [Full Text] [Related]
14. Tiotropium versus placebo for chronic obstructive pulmonary disease. Karner C, Chong J, Poole P. Cochrane Database Syst Rev; 2012 Jul 11; (7):CD009285. PubMed ID: 22786525 [Abstract] [Full Text] [Related]
15. A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD. Voshaar T, Lapidus R, Maleki-Yazdi R, Timmer W, Rubin E, Lowe L, Bateman E. Respir Med; 2008 Jan 11; 102(1):32-41. PubMed ID: 17996436 [Abstract] [Full Text] [Related]
16. The Tiotropium Safety and Performance in Respimat Trial (TIOSPIR), a large scale, randomized, controlled, parallel-group trial-design and rationale. Wise RA, Anzueto A, Calverley P, Dahl R, Dusser D, Pledger G, Koenen-Bergmann M, Joseph E, Cotton D, Disse B. Respir Res; 2013 Apr 02; 14(1):40. PubMed ID: 23547660 [Abstract] [Full Text] [Related]
17. Tiotropium Respimat(®) Versus HandiHaler(®): Comparison of Bronchodilator Efficacy of Various Doses in Clinical Trials. Calverley PM, Könen-Bergmann M, Richard F, Bell S, Hohlfeld JM. Adv Ther; 2016 May 02; 33(5):786-93. PubMed ID: 27084728 [Abstract] [Full Text] [Related]
18. TIOtropium Safety and Performance In Respimat® (TIOSPIRTM ): Analysis of Asian cohort of COPD patients. Zhong N, Moon HS, Lee KH, Mahayiddin AA, Boonsawat W, Isidro MG, Bai C, Mueller A, Metzdorf N, Anzueto A. Respirology; 2016 Nov 02; 21(8):1397-1403. PubMed ID: 27490162 [Abstract] [Full Text] [Related]
19. The Tiotropium Safety and Performance in Respimat® (TIOSPIR®) Trial: Spirometry Outcomes. Anzueto A, Wise R, Calverley P, Dusser D, Tang W, Metzdorf N, Dahl R. Respir Res; 2015 Sep 15; 16(1):107. PubMed ID: 26369563 [Abstract] [Full Text] [Related]